SG11201906920XA - Lactic acid bacteria, methods and uses thereof - Google Patents

Lactic acid bacteria, methods and uses thereof

Info

Publication number
SG11201906920XA
SG11201906920XA SG11201906920XA SG11201906920XA SG11201906920XA SG 11201906920X A SG11201906920X A SG 11201906920XA SG 11201906920X A SG11201906920X A SG 11201906920XA SG 11201906920X A SG11201906920X A SG 11201906920XA SG 11201906920X A SG11201906920X A SG 11201906920XA
Authority
SG
Singapore
Prior art keywords
international
lactic acid
acid bacteria
utilizing
pct
Prior art date
Application number
SG11201906920XA
Other languages
English (en)
Inventor
Stefan Roos
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of SG11201906920XA publication Critical patent/SG11201906920XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y105/00Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/03Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03048Protein-tyrosine-phosphatase (3.1.3.48)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01007Ethanolamine ammonia-lyase (4.3.1.7)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201906920XA 2017-03-27 2018-03-27 Lactic acid bacteria, methods and uses thereof SG11201906920XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1750363 2017-03-27
PCT/EP2018/057765 WO2018178072A1 (en) 2017-03-27 2018-03-27 Lactic acid bacteria, methods and uses thereof

Publications (1)

Publication Number Publication Date
SG11201906920XA true SG11201906920XA (en) 2019-08-27

Family

ID=61899234

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201906920XA SG11201906920XA (en) 2017-03-27 2018-03-27 Lactic acid bacteria, methods and uses thereof

Country Status (18)

Country Link
US (3) US11285181B2 (es)
EP (1) EP3601620A1 (es)
JP (1) JP7097382B2 (es)
KR (1) KR102673448B1 (es)
CN (1) CN110462022A (es)
AU (1) AU2018241852B2 (es)
BR (1) BR112019018344A2 (es)
CA (1) CA3052383A1 (es)
CL (1) CL2019002741A1 (es)
CO (1) CO2019011376A2 (es)
IL (1) IL269546B (es)
MX (1) MX2019011539A (es)
MY (1) MY193485A (es)
PH (1) PH12019502239A1 (es)
RU (1) RU2767340C2 (es)
SG (1) SG11201906920XA (es)
WO (1) WO2018178072A1 (es)
ZA (1) ZA201905024B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111423991B (zh) * 2019-11-18 2022-10-28 宁波大学 一种乳酸菌、筛选及应用
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
CN115197886B (zh) * 2022-09-14 2022-12-06 江苏朴厚环境工程有限公司 铜绿假单胞菌及其菌剂和在有机氮废水生物强化降解中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361643A (en) 1964-04-15 1968-01-02 Kikkoman Shoyu Co Ltd Method for cultivating micro-organisms having exoenzyme-producing ability
JPH09163976A (ja) 1995-12-15 1997-06-24 Mitsubishi Heavy Ind Ltd エタノールアミン分解菌及びエタノールアミン含有水の処理方法
NZ570635A (en) 2003-09-12 2010-04-30 New Image Internat Ltd Bio-active delivery system using lipids extracted from milk to coat the active substance
JP2005163976A (ja) * 2003-12-04 2005-06-23 Tokai Rubber Ind Ltd 筒形防振マウント
JP2005304362A (ja) 2004-04-20 2005-11-04 Nippon Shokubai Co Ltd 1,3−プロパンジオール及び/又は3−ヒドロキシプロピオン酸を製造する方法
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
WO2009078973A2 (en) 2007-12-13 2009-06-25 Glycos Biotechnologies, Incorporated Microbial conversion of oils and fatty acids to high-value chemicals
JP2009242275A (ja) * 2008-03-31 2009-10-22 Kagaku Shiryo Kenkyusho:Kk 生菌剤
ES2425385T3 (es) * 2009-04-30 2013-10-15 Actogenix N.V. Crioprotectores para la liofilización de las bacterias de ácido láctico
WO2011069987A1 (en) 2009-12-08 2011-06-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
RU2427624C1 (ru) * 2010-05-24 2011-08-27 Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) Способ замораживания молочно-кислых бактерий
JP5784327B2 (ja) * 2011-02-28 2015-09-24 森永乳業株式会社 抗菌剤
WO2012170021A1 (en) 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
WO2015168534A1 (en) * 2014-05-02 2015-11-05 Novogy, Inc. Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
HUP1500332A2 (en) 2015-07-16 2017-01-30 Feher Janos Dr Compositions for maintaining and restoring microbiota-host symbiosis
WO2018083336A1 (en) 2016-11-07 2018-05-11 Biogaia Ab Activated lactobacillus reuteri strains for selective pathogen inhibition in a human microbial community

Also Published As

Publication number Publication date
ZA201905024B (en) 2020-12-23
RU2019134200A3 (es) 2021-08-13
MX2019011539A (es) 2019-12-11
AU2018241852A1 (en) 2019-10-10
IL269546A (en) 2019-11-28
PH12019502239A1 (en) 2020-06-29
JP7097382B2 (ja) 2022-07-07
US11730780B2 (en) 2023-08-22
KR102673448B1 (ko) 2024-06-07
RU2767340C2 (ru) 2022-03-17
US20200038461A1 (en) 2020-02-06
US11285181B2 (en) 2022-03-29
RU2019134200A (ru) 2021-04-28
AU2018241852B2 (en) 2024-04-18
CO2019011376A2 (es) 2020-02-07
BR112019018344A2 (pt) 2020-03-31
KR20190132641A (ko) 2019-11-28
JP2020511971A (ja) 2020-04-23
MY193485A (en) 2022-10-17
CL2019002741A1 (es) 2020-02-21
US20220168365A1 (en) 2022-06-02
US20230338441A1 (en) 2023-10-26
CN110462022A (zh) 2019-11-15
EP3601620A1 (en) 2020-02-05
IL269546B (en) 2022-07-01
WO2018178072A1 (en) 2018-10-04
CA3052383A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201807195VA (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
SG11201803906PA (en) Control of cellular redox levels
SG11201807301SA (en) Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201806420RA (en) Compositions for controlled release of active ingredients and methods of making same
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201408303WA (en) Adhesive compositions of propylene-based and ethylene-based polymers
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201806057QA (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201806284TA (en) Low pressure separator having an internal divider and uses therefor
SG11201906920XA (en) Lactic acid bacteria, methods and uses thereof
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201811416VA (en) Crystalline solid forms of a bet inhibitor
SG11201803882PA (en) Oat-based product and process of manufacture
SG11201805001UA (en) Method of treating influenza a
SG11201804884PA (en) Method for modulating autophagy and applications thereof
SG11201907927SA (en) Binding molecules that specifically bind to tau
SG11201809551TA (en) Selection of bacterial strains useful in allergy treatment
SG11201806424TA (en) Therapeutic compounds
SG11201408509PA (en) Racecadotril lipid compositions
SG11201908605XA (en) Antifouling article